Literature DB >> 22398090

Maternal imprinting and female predominance in familial Crohn's disease.

Zuzana Zelinkova1, Pieter C Stokkers, Klaas van der Linde, Ernst J Kuipers, Maikel P Peppelenbosch, Christine P J van der Woude.   

Abstract

BACKGROUND AND AIM: Although the genetic risk factors for familial and sporadic inflammatory bowel disease (IBD) seem identical, the relative risk for contracting IBD in the familial setting is larger as that seen in the population at large, suggesting an important role of epi- and/or paragenetic factors in familial IBD. Epidemiological data indicate a female predominance in IBD, but how this relates to familial IBD has not been assessed.
METHODS: Familial IBD patients (N=608) were compared with a cohort of 415 sporadic IBD patients with regards to the patterns of sex and disease type distribution. The imprinting pattern in 87 families in which both a parent and a child had IBD was tested using Galton binominal statistics.
RESULTS: The percentage of females in familial IBD population was significantly higher (61%; female/male ratio 1.5) compared with sporadic IBD (54%; female/male ratio 1.2; p=0.011). The analysis of offspring sex distribution pattern revealed significantly higher female to female transmission compared with female to male transmission rate (36 vs. 18, respectively; p=0.02). A significantly higher number of mother to child transmissions (55 vs. 32 of father to child transmissions) was observed (p=0.018). The female imprinting was specifically related to Crohn's disease (31 vs. 14 mother vs. father to child transmissions, respectively; p=0.016).
CONCLUSION: We propose that a female sex-specific epigenetic inheritance pattern for Crohn's disease is a major contributing factor in the family-specific risk in Crohn's disease. Sex-specific manifestation of familial Crohn's disease can partly explain the epidemiologically observed increased relative risk for females for contracting IBD.
Copyright © 2012 European Crohn's and Colitis Organisation. Published by Elsevier B.V. All rights reserved.

Entities:  

Mesh:

Year:  2012        PMID: 22398090     DOI: 10.1016/j.crohns.2012.01.002

Source DB:  PubMed          Journal:  J Crohns Colitis        ISSN: 1873-9946            Impact factor:   9.071


  10 in total

1.  Linkage between genotype and immunological phenotype in Crohn's disease.

Authors:  Gwenny M Fuhler; Kaushal Parikh; C Janneke van der Woude; Maikel P Peppelenbosch
Journal:  Ann Transl Med       Date:  2015-09

2.  Limited evidence for parent-of-origin effects in inflammatory bowel disease associated loci.

Authors:  Karin Fransen; Mitja Mitrovic; Cleo C van Diemen; B K Thelma; Ajit Sood; Andre Franke; Stefan Schreiber; Vandana Midha; Garima Juyal; Uros Potocnik; Jingyuan Fu; Ilja Nolte; Rinse K Weersma
Journal:  PLoS One       Date:  2012-09-27       Impact factor: 3.240

Review 3.  The history of genetics in inflammatory bowel disease.

Authors:  Weronica E Ek; Mauro D'Amato; Jonas Halfvarson
Journal:  Ann Gastroenterol       Date:  2014

4.  A dietary intervention to improve the microbiome composition of pregnant women with Crohn's disease and their offspring: The MELODY (Modulating Early Life Microbiome through Dietary Intervention in Pregnancy) trial design.

Authors:  Inga Peter; Ana Maldonado-Contreras; Caroline Eisele; Christine Frisard; Shauna Simpson; Nilendra Nair; Alexa Rendon; Kelly Hawkins; Caitlin Cawley; Anketse Debebe; Leonid Tarassishin; Sierra White; Marla Dubinsky; Joanne Stone; Jose C Clemente; Joao Sabino; Joana Torres; Jianzhong Hu; Jean-Frederic Colombel; Barbara Olendzki
Journal:  Contemp Clin Trials Commun       Date:  2020-05-04

Review 5.  Sex-based differences in inflammatory bowel diseases: a review.

Authors:  Sheila D Rustgi; Maia Kayal; Shailja C Shah
Journal:  Therap Adv Gastroenterol       Date:  2020-04-28       Impact factor: 4.409

6.  Distinct clinical phenotypes for Crohn's disease derived from patient surveys.

Authors:  Tianyun Liu; Lichy Han; Mera Tilley; Lovisa Afzelius; Mateusz Maciejewski; Scott Jelinsky; Chao Tian; Matthew McIntyre; Nan Bing; Kenneth Hung; Russ B Altman
Journal:  BMC Gastroenterol       Date:  2021-04-09       Impact factor: 3.067

7.  Polyphenol Enriched Diet Administration During Pregnancy and Lactation Prevents Dysbiosis in Ulcerative Colitis Predisposed Littermates.

Authors:  Stefania De Santis; Aurelia Scarano; Marina Liso; Francesco Maria Calabrese; Giulio Verna; Elisabetta Cavalcanti; Annamaria Sila; Antonio Lippolis; Maria De Angelis; Angelo Santino; Marcello Chieppa
Journal:  Front Cell Infect Microbiol       Date:  2021-06-09       Impact factor: 5.293

Review 8.  Familial and ethnic risk in inflammatory bowel disease.

Authors:  Maria Pia Costa Santos; Catarina Gomes; Joana Torres
Journal:  Ann Gastroenterol       Date:  2017-10-26

9.  Occurrence of skin manifestations in patients of the Swiss Inflammatory Bowel Disease Cohort Study.

Authors:  Nina Roth; Luc Biedermann; Nicolas Fournier; Matthias Butter; Stephan R Vavricka; Alexander A Navarini; Gerhard Rogler; Michael Scharl
Journal:  PLoS One       Date:  2019-01-25       Impact factor: 3.240

Review 10.  Food as Treatment of Inflammatory Bowel Diseases.

Authors:  Ana Maldonado-Contreras
Journal:  Infect Immun       Date:  2022-05-11       Impact factor: 3.609

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.